Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...

GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

Shares of biotechnology stocks such as Recursion Pharmaceuticals (NASDAQ: RXRX), Summit Therapeutics (NASDAQ: SMMT), and CRISPR Therapeutics AG (NASDAQ: CRSP) plunged on Monday, down 9.4% ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Recursion Pharmaceuticals uses artificial intelligence ... as well as some cancers. Summit Therapeutics is much larger than the other two stocks, thanks to last year's promising Phase III results ...

The ALS research landscape is evolving rapidly, with groundbreaking advancements shaping the future of therapeutic ...

Chief Operating Officer of Tonix Pharmaceuticals, will present at the 2025 Virtual Investor Summit on Tuesday, March 11, 2025, at 10:30 a.m. ET.

The summit commenced with the GCC Regulatory Affairs Pharma Summit on February 17-18, setting the stage for thought-provoking discussions on critical regulatory topics. The Tribune, now published ...

The pharma industry, Wall Street and former government officials on Monday decried the forced resignation of FDA vaccine ...

Piramal believes that while passing the baton of the group's business, it is crucial for leaders—especially those accustomed ...

Dubai [UAE], March 3 (ANI/ ARAB NEWSWIRE): The 10th edition of the GCC Regulatory Affairs Pharma Summit, held at the prestigious Mövenpick Grand Al Bustan in Dubai, concluded with tremendous success.